U
Celyad Oncology SA CLYYF
$0.25 -$0.10-28.57% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Corporate Info
Website
Phone Number
32 1 039 41 00
Address
Axis Business Park
Rue Emile Francqui 6
Mont-Saint-Guibert, 1435
Country
Belgium
Year Founded
2004
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
5
Business Description
Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.